indazoles has been researched along with donepezil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capriati, V; Cardoso, SM; Chaves, S; Costa, M; Gwizdala, K; Josselin, R; Pereira-Santos, AR; Piemontese, L; Resta, S; Rinaldo, F; Santos, MA | 1 |
| Fang, L; Gou, S; Liu, Q; Liu, Z; Zhang, B | 1 |
2 other study(ies) available for indazoles and donepezil
| Article | Year |
|---|---|
Design, Synthesis, and In Vitro Evaluation of Hydroxybenzimidazole-Donepezil Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Chelating Agents; Cholinesterase Inhibitors; Donepezil; Humans; Indazoles; Ligands; Molecular Docking Simulation; Molecular Structure; Piperazine; Piperidines; Structure-Activity Relationship | 2020 |
Blood-Brain Barrier Permeable and NO-Releasing Multifunctional Nanoparticles for Alzheimer's Disease Treatment: Targeting NO/cGMP/CREB Signaling Pathways.
Topics: Alzheimer Disease; Animals; Apoptosis; Cell Line, Tumor; Donepezil; Drug Carriers; Drug Liberation; Humans; Indazoles; Male; Memory; Mice, Inbred BALB C; Mice, Nude; Multifunctional Nanoparticles; Neuronal Plasticity; Neurons; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Donors; Nootropic Agents; Oxadiazoles; Purines; Pyrazoles; Rats, Sprague-Dawley; Signal Transduction | 2021 |